{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:38:07Z","timestamp":1787168287492,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10072-025-08089-8","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:43:30Z","timestamp":1742258610000},"page":"3175-3182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Frailty and urinary symptoms share pathophysiological mechanisms involved in disease progression in people with multiple sclerosis"],"prefix":"10.1007","volume":"46","author":[{"given":"Angelo","family":"Di Santo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Malimpensa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Canevelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Zampelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Belvisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Leodori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Giannantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8433-9148","authenticated-orcid":false,"given":"Gina","family":"Ferrazzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"8089_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G (2019) Multiple sclerosis - a review. Eur J Neurol 26:27\u201340. https:\/\/doi.org\/10.1111\/ene.13819","journal-title":"Eur J Neurol"},{"key":"8089_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1179\/2045772315Y.0000000021","volume":"39","author":"Y Akko\u00e7","year":"2016","unstructured":"Akko\u00e7 Y, Ers\u00f6z M, Y\u00fcceyar N et al (2016) Overactive bladder symptoms in patients with multiple sclerosis: frequency, severity, diagnosis and treatment. J Spinal Cord Med 39:229\u2013233. https:\/\/doi.org\/10.1179\/2045772315Y.0000000021","journal-title":"J Spinal Cord Med"},{"key":"8089_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5489\/cuaj.4058","volume":"11","author":"SM Aharony","year":"2017","unstructured":"Aharony SM, Lam O, Corcos J (2017) Evaluation of lower urinary tract symptoms in multiple sclerosis patients: review of the literature and current guidelines. Can Urol Assoc J 11:61\u201364. https:\/\/doi.org\/10.5489\/cuaj.4058","journal-title":"Can Urol Assoc J"},{"key":"8089_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0022-5347(01)61760-9","volume":"162","author":"SE Litwiller","year":"1999","unstructured":"Litwiller SE, Frohman EM, Zimmern PE (1999) Multiple sclerosis and the urologist. J Urol 162:743\u2013757","journal-title":"J Urol"},{"key":"8089_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5603\/PJNNS.a2023.0035","volume":"57","author":"K Kania","year":"2023","unstructured":"Kania K, Ambrosius W, Dyczkowska K et al (2023) Prevalence and prognostic value of prodromal symptoms in relapsing-remitting multiple sclerosis. Neurol Neurochir Pol 57:289\u2013296. https:\/\/doi.org\/10.5603\/PJNNS.a2023.0035","journal-title":"Neurol Neurochir Pol"},{"key":"8089_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/s0022-510x(01)00572-x","volume":"189","author":"R Bergamaschi","year":"2001","unstructured":"Bergamaschi R, Berzuini C, Romani A, Cosi V (2001) Predicting secondary progression in relapsing-remitting multiple sclerosis: A bayesian analysis. J Neurol Sci 189:13\u201321. https:\/\/doi.org\/10.1016\/s0022-510x(01)00572-x","journal-title":"J Neurol Sci"},{"key":"8089_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/nau.24206","volume":"39","author":"AL Smith","year":"2020","unstructured":"Smith AL, Weissbart SJ, Hartigan SM et al (2020) Association between urinary symptom severity and white matter plaque distribution in women with multiple sclerosis. Neurourol Urodyn 39:339\u2013346. https:\/\/doi.org\/10.1002\/nau.24206","journal-title":"Neurourol Urodyn"},{"key":"8089_CR8","doi-asserted-by":"publisher","first-page":"e200064","DOI":"10.1212\/NXI.0000000000200064","volume":"10","author":"T Ziemssen","year":"2023","unstructured":"Ziemssen T, Bhan V, Chataway J et al (2023) Secondary progressive multiple sclerosis A review of clinical characteristics, definition, prognostic tools, and Disease-Modifying therapies. Neurol Neuroimmunol Neuroinflamm 10:e200064. https:\/\/doi.org\/10.1212\/NXI.0000000000200064","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"8089_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1212\/WNL.0000000000012323","volume":"97","author":"BAC Cree","year":"2021","unstructured":"Cree BAC, Arnold DL, Chataway J et al (2021) Secondary Progressive Multiple Sclerosis: New Insights Neurol 97:378\u2013388. https:\/\/doi.org\/10.1212\/WNL.0000000000012323","journal-title":"Secondary Progressive Multiple Sclerosis: New Insights Neurol"},{"key":"8089_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.7224\/1537-2073.2019-030","volume":"22","author":"HB Al Dandan","year":"2020","unstructured":"Al Dandan HB, Coote S, McClurg D (2020) Prevalence of lower urinary tract symptoms in people with multiple sclerosis: A systematic review and Meta-analysis. Int J MS Care 22:91\u201399. https:\/\/doi.org\/10.7224\/1537-2073.2019-030","journal-title":"Int J MS Care"},{"key":"8089_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.mad.2019.04.005","volume":"180","author":"K Rockwood","year":"2019","unstructured":"Rockwood K, Howlett SE (2019) Age-related deficit accumulation and the diseases of ageing. Mech Ageing Dev 180:107\u2013116. https:\/\/doi.org\/10.1016\/j.mad.2019.04.005","journal-title":"Mech Ageing Dev"},{"key":"8089_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s41999-018-0102-y","volume":"9","author":"N Veronese","year":"2018","unstructured":"Veronese N, Soysal P, Stubbs B et al (2018) Association between urinary incontinence and frailty: a systematic review and meta-analysis. Eur Geriatr Med 9:571\u2013578. https:\/\/doi.org\/10.1007\/s41999-018-0102-y","journal-title":"Eur Geriatr Med"},{"key":"8089_CR13","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1097\/QAD.0000000000000753","volume":"29","author":"G Guaraldi","year":"2025","unstructured":"Guaraldi G, Brothers TD, Zona S et al (2025) A frailty index predicts survival and incident Multimorbidity independent of markers of HIV disease severity. AIDS 29:1633\u20131641","journal-title":"AIDS"},{"key":"8089_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3899\/jrheum.181338","volume":"47","author":"A Legge","year":"2020","unstructured":"Legge A, Kirkland S, Rockwood K et al (2020) Construction of a frailty index as a novel health measure in systemic lupus erythematosus. J Rheumatol 47:72\u201381","journal-title":"J Rheumatol"},{"key":"8089_CR15","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1177\/1352458520987541","volume":"27","author":"D Belvisi","year":"2021","unstructured":"Belvisi D, Canevelli M, Baione V et al (2021) Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation. Mult Scler 27:1939\u20131947. https:\/\/doi.org\/10.1177\/1352458520987541","journal-title":"Mult Scler"},{"key":"8089_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/1352458520923945","volume":"27","author":"X Ayrignac","year":"2021","unstructured":"Ayrignac X, Larochelle C, Keezer M et al (2021) Frailty in ageing persons with multiple sclerosis. Mult Scler 27:613\u2013620. https:\/\/doi.org\/10.1177\/1352458520923945","journal-title":"Mult Scler"},{"key":"8089_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"key":"8089_CR18","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/wnl.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444\u20131452. https:\/\/doi.org\/10.1212\/wnl.33.11.1444","journal-title":"Neurology"},{"key":"8089_CR19","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/nau.23420","volume":"37","author":"AC Peterson","year":"2018","unstructured":"Peterson AC, Sehgal A, Crump RT et al (2018) Evaluating the 8-item overactive bladder questionnaire (OAB-v8) using item response theory. Neurourol Urodyn 37:1095\u20131100. https:\/\/doi.org\/10.1002\/nau.23420","journal-title":"Neurourol Urodyn"},{"key":"8089_CR20","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s00192-013-2134-7","volume":"24","author":"F Possavino","year":"2013","unstructured":"Possavino F, Preti M, Carone R et al (2013) Psychometric validation of the Italian version of the I-QoL questionnaire: clinical and urodynamic findings. Int Urogynecol J 24:2125\u20132130. https:\/\/doi.org\/10.1007\/s00192-013-2134-7","journal-title":"Int Urogynecol J"},{"key":"8089_CR21","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/nau.23124","volume":"36","author":"PFWM Rosier","year":"2017","unstructured":"Rosier PFWM, Schaefer W, Lose G et al (2017) International continence society good urodynamic practices and terms 2016: urodynamics, uroflowmetry, cystometry, and pressure-flow study. Neurourol Urodyn 36:1243\u20131260. https:\/\/doi.org\/10.1002\/nau.23124","journal-title":"Neurourol Urodyn"},{"key":"8089_CR22","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1464-410x.1990.tb14791.x","volume":"65","author":"BT Haylen","year":"1990","unstructured":"Haylen BT, Parys BT, Anyaegbunam WI et al (1990) Urine flow rates in male and female urodynamic patients compared with the Liverpool nomograms. Br J Urol 65:483\u2013487. https:\/\/doi.org\/10.1111\/j.1464-410x.1990.tb14791.x","journal-title":"Br J Urol"},{"key":"8089_CR23","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/s0090-4295(03)00010-4","volume":"61","author":"R Kranse","year":"2003","unstructured":"Kranse R, van Mastrigt R (2003) Causes for variability in repeated pressure-flow measurements. Urology 61:930\u2013935. https:\/\/doi.org\/10.1016\/s0090-4295(03)00010-4","journal-title":"Urology"},{"key":"8089_CR24","first-page":"1","volume":"8","author":"JD McConnell","year":"1994","unstructured":"McConnell JD, Barry MJ, Bruskewitz RC (1994) Benign prostatic hyperplasia: diagnosis and treatment. Agency for health care policy and research. Clinical practice guidelines quick reference guide for clinicians. Clin Pract Guidel Quick Ref Guide Clin 8:1\u201317","journal-title":"Clin Pract Guidel Quick Ref Guide Clin"},{"key":"8089_CR25","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1097\/01.ju.0000140502.34334.7","volume":"172","author":"M Milleman","year":"2004","unstructured":"Milleman M, Langenstroer P, Guralnick ML (2004) Post-void residual urine volume in women with overactive bladder symptoms. J Urol 172:1911\u20131914. https:\/\/doi.org\/10.1097\/01.ju.0000140502.34334.7","journal-title":"J Urol"},{"key":"8089_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1100\/tsw.2001.58","volume":"1","author":"AB Mitnitski","year":"2001","unstructured":"Mitnitski AB, Mogilner AJ, Rockwood K (2001) Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal 1:323\u2013336","journal-title":"ScientificWorldJournal"},{"key":"8089_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2318-8-24","volume":"8","author":"SD Searle","year":"2008","unstructured":"Searle SD, Mitnitski A, Gahbauer EA et al (2008) A standard procedure for creating a frailty index. BMC Geriatr 8:24. https:\/\/doi.org\/10.1186\/1471-2318-8-24","journal-title":"BMC Geriatr"},{"issue":"7","key":"8089_CR28","doi-asserted-by":"publisher","first-page":"e0271688","DOI":"10.1371\/journal.pone.0271688","volume":"17","author":"T Zanotto","year":"2022","unstructured":"Zanotto T, Rice LA, Sosnoff JJ (2022) Frailty among people with multiple sclerosis who are wheelchair users. PLoS ONE 17(7):e0271688. https:\/\/doi.org\/10.1371\/journal.pone.0271688","journal-title":"PLoS ONE"},{"key":"8089_CR29","doi-asserted-by":"publisher","first-page":"1138600","DOI":"10.3389\/fneur.2023.1138600","volume":"14","author":"M Tartaglia","year":"2023","unstructured":"Tartaglia M, Canevelli M, Malimpensa L et al (2023) Neurophysiological and clinical biomarkers of secondary progressive multiple sclerosis: A cross-sectional study. Front Neurol 14:1138600. https:\/\/doi.org\/10.3389\/fneur.2023.1138600","journal-title":"Front Neurol"},{"key":"8089_CR30","doi-asserted-by":"publisher","first-page":"104603","DOI":"10.1016\/j.msard.2023.104603","volume":"72","author":"V Baione","year":"2023","unstructured":"Baione V, Canevelli M, Belvisi D et al (2023) Frailty and relapse activity in multiple sclerosis: A longitudinal observation. Mult Scler Relat Disord Apr 72:104603. https:\/\/doi.org\/10.1016\/j.msard.2023.104603","journal-title":"Mult Scler Relat Disord Apr"},{"key":"8089_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12894-020-00590-w","volume":"20","author":"F Nazari","year":"2020","unstructured":"Nazari F, Shaygannejad V, Mohammadi Sichani M et al (2020) Quality of life among patients with multiple sclerosis and voiding dysfunction: a cross-sectional study. BMC Urol 20:62. https:\/\/doi.org\/10.1186\/s12894-020-00590-w","journal-title":"BMC Urol"},{"key":"8089_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrn2401","volume":"9","author":"CJ Fowler","year":"2008","unstructured":"Fowler CJ, Griffiths D, de Groat WC (2008) The neural control of micturition. Nat Rev Neurosci 9:453\u2013466. https:\/\/doi.org\/10.1038\/nrn2401","journal-title":"Nat Rev Neurosci"},{"key":"8089_CR33","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/s1053-8119(03)00117-4","volume":"19","author":"A Charil","year":"2003","unstructured":"Charil A, Zijdenbos AP, Taylor J et al (2003) Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. NeuroImage 19:532\u2013544. https:\/\/doi.org\/10.1016\/s1053-8119(03)00117-4","journal-title":"NeuroImage"},{"key":"8089_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/biom12020222","volume":"12","author":"F Azzolini","year":"2022","unstructured":"Azzolini F, Gilio L, Pavone L et al (2022) Neuroinflammation is associated with GFAP and sTREM2 levels in multiple sclerosis. Biomolecules 12:222. https:\/\/doi.org\/10.3390\/biom12020222","journal-title":"Biomolecules"},{"key":"8089_CR35","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.2174\/0929867326666190717152739","volume":"26","author":"P Brivio","year":"2019","unstructured":"Brivio P, Paladini MS, Racagni G et al (2019) From healthy aging to frailty: in search of the underlying mechanisms. Curr Med Chem 26:3685\u20133701. https:\/\/doi.org\/10.2174\/0929867326666190717152739","journal-title":"Curr Med Chem"},{"key":"8089_CR36","doi-asserted-by":"publisher","unstructured":"Galluzzo L, Noale M, Maggi S et al (2022) Incidence, and Association with Incident Disability in the Italian Longitudinal Study on Aging. Gerontology. 2023;69(3):249\u2013260. https:\/\/doi.org\/10.1159\/000525581","DOI":"10.1159\/000525581"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08089-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08089-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08089-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:46:00Z","timestamp":1749516360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08089-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["8089"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08089-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the local ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors state that there is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}